<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03417518</url>
  </required_header>
  <id_info>
    <org_study_id>B076201420067</org_study_id>
    <nct_id>NCT03417518</nct_id>
  </id_info>
  <brief_title>Effects of Anesthesia With Propofol Versus Desflurane in Obese Patients</brief_title>
  <official_title>Effects of General Anesthesia With Propofol Versus Desflurane on Oxidative Stress and Inflammation in Obese Patients Scheduled for Bariatric Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire Saint Pierre</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire Saint Pierre</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Evaluate the effects of propofol compared with desflurane on oxidative stress and
      inflammation markers in obese patients undergoing scheduled bariatric surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Obese patients have a high level of oxidative stress and inflammation activity. Desflurane is
      an anesthetic gas often used for obese patients. Propofol, another anesthetic agent, has
      shown an antioxidant property. The aim of the study is to compare the effects of propofol
      with desflurane on oxidative stress and inflammation markers in obese patients.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 2015</start_date>
  <completion_date type="Actual">September 2016</completion_date>
  <primary_completion_date type="Actual">October 2015</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Malondialdehyde (MDA) level in blood sample</measure>
    <time_frame>up to 24 hours post bariatric surgery</time_frame>
    <description>Plasma MDA level is measured as an oxidative stress marker before the surgery, at 1 hour, 2 hours, 24 hours post-surgical incision.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>C-Reactive Protein (CRP) in blood sample</measure>
    <time_frame>up to 24 hours post bariatric surgery</time_frame>
    <description>Plasma CRP level is measured as an inflammation marker before the surgery, at 1 hour, 2 hours, 24 hours post-surgical incision.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Monocyte level in blood sample</measure>
    <time_frame>up to 24 hours post bariatric surgery</time_frame>
    <description>Monocyte level is measured as an inflammation marker before the surgery, at 1 hour, 2 hours, 24 hours post-surgical incision.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain assessed by Visual Analog Scale (VAS)</measure>
    <time_frame>up to 48 hours after surgery</time_frame>
    <description>Pain level is determined at 2 hours, 24 hours and 48 hours post-surgical incision. Visual analog pain score (scale = 0 no pain; 10= worst pain imaginable)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Side-effects (nausea, vomiting, somnolence, respiratory depression)</measure>
    <time_frame>up to 48 hours after surgery</time_frame>
    <description>Evaluation at 2 hours, 24 hours and 48 hours post-surgical incision</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Anesthesia</condition>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>Desflurane Inhalant Product Group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>general anesthesia with desflurane</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Propofol Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>general anesthesia with propofol</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Desflurane Inhalant Product</intervention_name>
    <description>General anesthesia will be induced with sufentanyl (0.2µg/kg) and thiopental (5mg/kg) and maintained by desflurane</description>
    <arm_group_label>Desflurane Inhalant Product Group</arm_group_label>
    <other_name>Suprane</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Propofol</intervention_name>
    <description>General anesthesia will be induced with propofol (2mg/kg) and sufentanyl (0.2µg/kg) and maintained by propofol in a target-controlled infusion mode</description>
    <arm_group_label>Propofol Group</arm_group_label>
    <other_name>Diprivan</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Body Mass Index (BMI) &gt;35

          -  scheduled gastric by pass surgery

          -  American Society of Anesthesiologists (ASA) &lt;III

        Exclusion Criteria:

          -  Allergic to anesthesia agent

          -  patient refusal
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Panayota Kapessidou</last_name>
    <role>Study Director</role>
    <affiliation>University Hospital Saint-Pierre (CHU Saint-Pierre), Universite libre de Bruxelles (ULB)</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Livia Di Marco, doctor</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital Saint-Pierre (CHU Saint-Pierre)</affiliation>
  </overall_official>
  <reference>
    <citation>Skalicky J, Muzakova V, Kandar R, Meloun M, Rousar T, Palicka V. Evaluation of oxidative stress and inflammation in obese adults with metabolic syndrome. Clin Chem Lab Med. 2008;46(4):499-505. doi: 10.1515/CCLM.2008.096.</citation>
    <PMID>18298345</PMID>
  </reference>
  <reference>
    <citation>Del Rio D, Stewart AJ, Pellegrini N. A review of recent studies on malondialdehyde as toxic molecule and biological marker of oxidative stress. Nutr Metab Cardiovasc Dis. 2005 Aug;15(4):316-28. Review.</citation>
    <PMID>16054557</PMID>
  </reference>
  <reference>
    <citation>Murphy PG, Myers DS, Davies MJ, Webster NR, Jones JG. The antioxidant potential of propofol (2,6-diisopropylphenol). Br J Anaesth. 1992 Jun;68(6):613-8.</citation>
    <PMID>1319189</PMID>
  </reference>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 25, 2018</study_first_submitted>
  <study_first_submitted_qc>January 25, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">January 31, 2018</study_first_posted>
  <last_update_submitted>February 8, 2018</last_update_submitted>
  <last_update_submitted_qc>February 8, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 9, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Oxidative stress</keyword>
  <keyword>Bariatric surgery</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Propofol</mesh_term>
    <mesh_term>Desflurane</mesh_term>
    <mesh_term>Isoflurane</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

